| Structure of Cathepsin S in complex with Compound 20b | | homo-2-mer | 113-331 | 100 | 7×EDO; 2×FLC; 3×SO4; 2×Q1N; |
|
| Structure of Cathepsin S in complex with Compound 14 | | homo-2-mer | 113-331 | 100 | 2×FLC; 2×Q1E; 6×SO4; |
|
| Structure of Cathepsin S in complex with Compound 1 | | homo-2-mer | 114-331 | 100 | 4×SO4; 32×EDO; 1×DMS; 2×Q1K; 1×FLC; |
|
| Structure of Cathepsin S in complex with Compound 2 | | homo-2-mer | 114-331 | 100 | 6×ACT; 1×Q1H; 1×SIN; 2×MLA; |
|
| Structure of Cathepsin S in complex with Compound 3 | | homo-2-mer | 114-331 | 100 | 1×Q1Q; |
|
| THE CRYSTAL STRUCTURE OF A CYS25ALA MUTANT OF HUMAN PROCATHEPSIN S | | monomer | 18-331 | 99.67 | |
|
| Cathepsin S in complex with non covalent arylaminoethyl amide. | | monomer | 112-331 | 100 | 4×SO4; |
|
| Cathepsin S in complex with non-covalent 2-(Benzoxazol-2-ylamino)-acetamide | | monomer | 112-331 | 100 | 1×GNF; |
|
| Cathepsin S in complex with NNPI-C10 inhibitor | | monomer | 113-331 | 100 | 4×EDO; 1×PGE; 1×NO3; 1×GOL; 1×PEG; |
|
| Cathepsin S Y132D mutant in complex with NNPI-C10 inhibitor | | monomer | 113-331 | 99.54 | 5×CL; 1×GOL; 5×EDO; 4×CD; 2×ACT; 3×PEG; |
|
| Crystal structure of human cathepsin S produced in insect cells in complex with ketoamide 13b | | monomer | 114-331 | 100 | 1×KH0; 2×EDO; 2×DMS; |
|
| Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor. | | monomer | 114-331 | 100 | 1×H7J; 1×P15; |
|
| Crystal Structure of Human Cathepsin S Bound to a Non-covalent Inhibitor. | | monomer | 114-331 | 100 | 1×2FZ; |
|
| Human Cathepsin S with Inhibitor CRA-26871 | | monomer | 114-331 | 100 | 1×C71; |
|
| Cathepsin S with nitrile inhibitor | | monomer | 114-331 | 100 | 1×CRJ; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BFV; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×N2D; |
|
| Crystal Structure of Human Cathepsin S Bound to a Non-covalent Inhibitor | | monomer | 114-331 | 100 | 1×SO4; 1×2FC; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BGY; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BQS; 3×EOH; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BQJ; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BHJ; 1×SO4; |
|
| Human Cathepsin S with Inhibitor CRA-27566 | | monomer | 114-331 | 100 | 1×CRL; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×B9Y; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BC7; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BG7; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BJY; 1×SO4; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×B9S; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×B8V; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BCJ; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×SO4; 1×GOL; 1×BJV; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BHV; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×SO4; 1×BJS; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×N2A; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BGJ; 3×SO4; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BAJ; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 114-331 | 99.54 | 1×BJD; |
|
| Cathepsin S in complex with a covalent inhibitor with an aldehyde warhead | | monomer | 115-331 | 100 | 1×O64; 1×DMS; |
|
| The structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substr… | | monomer | 115-331 | 100 | 1×SO4; 1×TF5; 1×PEU; |
|
| 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is crit… | | monomer | 115-331 | 100 | 1×PEG; 1×DMS; 1×935; 1×93N; |
|
| Human Cathepsin S with Inhibitor CRA-29728 | | monomer | 115-331 | 100 | 1×C28; |
|
| Crystal Structure of Cathepsin S in complex with a Zinc mediated non-covalent arylaminoethyl amide | | monomer | 115-331 | 100 | 3×ZN; 1×CL; 1×GNQ; |
|
| Crystal structures of Cathepsin S inhibitor complexes | | monomer | 115-331 | 99.54 | 1×C4P; |
|
| Human Cathepsin S with CRA-27934, a Nitrile Inhibitor | | monomer | 115-331 | 100 | 1×CRV; |
|
| Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor (Hexagonal spacegroup) | | monomer | 115-331 | 100 | 1×SO4; 1×H7J; |
|
| 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors | | monomer | 115-331 | 100 | 1×EF3; 1×DMS; |
|
| Dipeptide Nitrile Inhibitor Bound to Cathepsin S. | | monomer | 115-331 | 100 | 1×BLN; |
|
| Cathepsin S complexed with Compound 15 | | monomer | 115-331 | 100 | 1×Y11; |
|
| Crystal structures of Cathepsin S inhibitor complexes | | monomer | 115-331 | 99.54 | 1×C1P; |
|
| Human Cathepsin S with inhibitor CRA-16981 | | monomer | 115-331 | 100 | 1×MO9; |
|
| Cathepsin S complexed with Compound 26 | | monomer | 115-331 | 100 | 1×Y14; |
|
| Cathepsin S complexed with Compound 8 | | monomer | 115-331 | 100 | 1×Y15; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 115-331 | 99.54 | 1×BJD; 1×SO4; 1×GOL; |
|
| Pyrazole-based Cathepsin S Inhibitors with Arylalkynes as P1 Binding Elements | | monomer | 115-331 | 99.54 | 1×599; |
|
| Crystal Structure of Cys25Ser mutant of human cathepsin S | | monomer | 115-331 | 99.08 | |
|
| Mutant Human Cathepsin S with irreversible inhibitor CRA-14013 | | monomer | 115-331 | 98.16 | 1×BCQ; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 115-331 | 99.54 | 1×BQP; |
|
| Human cathepsin S mutant with vinyl sulfone inhibitor CRA-14009 | | monomer | 115-331 | 99.08 | 1×MQQ; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 115-331 | 99.54 | 1×SO4; 1×BJJ; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 115-331 | 99.54 | 1×B8J; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 115-331 | 99.54 | 1×B8Y; |
|
| Crystal structure of human Cathepsin-S with bound ligand | | monomer | 115-331 | 99.54 | 1×B8S; |
|